Literature DB >> 17168435

Factors influencing axillary node metastasis in breast cancer.

Sibel Kahraman Cetintaş1, Meral Kurt, Lütfi Ozkan, Kayihan Engin, Sehsuvar Gökgöz, Ismet Taşdelen.   

Abstract

AIMS AND
BACKGROUND: The status of the axillary lymph nodes at the time of diagnosis has been accepted as one of the most important prognostic factors for the overall and disease-free survival of patients with breast cancer. The aim of our study was to determine which factors influence axillary node involvement in invasive breast cancer.
METHODS: The data presented here were obtained from 344 patients who were treated for invasive breast cancer at the Department of Radiation Oncology, Uludağ University Medical College, Bursa, Turkey. Possible prognostic factors were categorized as patient related and tumor related. The Mann-Whitney U test was used for univariate analysis and logistic regression was used for multivariate analysis.
RESULTS: In univariate analysis, a familial cancer history (P = 0.0042), age < 40 years (P = 0.0276), higher T stage (P < 0.0000), nipple involvement (P = 0.0345), skin involvement (P = 0.0270), perineural invasion (P = 0.0231), and lymphatic vessel invasion (P < 0.0000) were correlated with increased axillary node involvement. A higher incidence of > or = 4 involved lymph nodes was associated with higher T stage (P = 0.0004), nipple involvement (P = 0.0292), presence of an extensive intraductal component (P = 0.0023), skin involvement (P = 0.0008), perineural invasion (P = 0.0523), and lymphatic vessel invasion (P < 0.0000) in univariate analysis. In multivariate analysis, age < 40 years (P = 0.0454), cancer history within the family (P = 0.0024), higher T stage (P = 0.0339), lymphatic vessel invasion (P = 0.0003), and perineural invasion (P = 0.0408) were found to be independent factors for axillary lymph node positivity. Age < 40 years (P = 0.0221), perineural invasion (P = 0.0408), and an extensive intraductal component (P = 0.0132) were associated with an increased incidence of > or = 4 involved nodes in the logistic regression analysis. In patients with breast cancer, the incidence of axillary lymph node involvement was independently influenced by age < 40 years, presence of cancer history within the family, higher T stage, lymphatic vessel invasion, and perineural invasion.
CONCLUSIONS: In conclusion, absence of familial cancer history, presence of lymphatic vessel invasion, higher T stage, and age below 40 years independently increased the risk of axillary node involvement. Presence of perineural invasion and lymphatic vessel invasion, age below 40, and an extensive intraductal component of more than 25% independently affected the risk of having > or = 4 nodes involved. Patients characterized by these factors may be classified into a higher risk group for nodal involvement, but more data are needed to define factors that can help in the decision-making regarding the omission of axillary treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17168435     DOI: 10.1177/030089160609200509

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  8 in total

1.  Statistical models for predicting number of involved nodes in breast cancer patients.

Authors:  Alok Kumar Dwivedi; Sada Nand Dwivedi; Suryanarayana Deo; Rakesh Shukla; Elizabeth Kopras
Journal:  Health (Irvine Calif)       Date:  2010-07

2.  Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size.

Authors:  Jong Hoon Lee; Sung Hwan Kim; Young Jin Suh; Byoung Yong Shim; Hoon Kyo Kim
Journal:  Cancer Res Treat       Date:  2010-03-31       Impact factor: 4.679

3.  The role of surgery for pancreatic cancer: a 12-year review of patient outcome.

Authors:  S A Badger; J L Brant; C Jones; J McClements; M B Loughrey; M A Taylor; T Diamond; L D McKie
Journal:  Ulster Med J       Date:  2010-05

4.  Correlation of Various Biomarkers with Axillary Nodal Metastases: Can a Panel of Such Biomarkers Guide Selective Use of Axillary Surgery in T1 Breast Cancer?

Authors:  Tufale A Dass; Sharma Rakesh; K Patil Prakash; Chandraveer Singh
Journal:  Indian J Surg Oncol       Date:  2015-07-24

5.  Axillary lymph node status in multicentric breast tumors and breast tumors with nipple involvement.

Authors:  Murat Cakir; Ahmet Tekin; Tevfik Kücükkartallar; Celalettin Vatansev; Faruk Aksoy; Adil Kartal; Fatma B Tuncer
Journal:  Breast Care (Basel)       Date:  2012-10       Impact factor: 2.860

6.  Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.

Authors:  Siddhartha Deb; Nicholas Jene; Stephen B Fox
Journal:  BMC Cancer       Date:  2012-11-09       Impact factor: 4.430

7.  A logistic regression model for predicting axillary lymph node metastases in early breast carcinoma patients.

Authors:  Fei Xie; Houpu Yang; Shu Wang; Bo Zhou; Fuzhong Tong; Deqi Yang; Jiaqing Zhang
Journal:  Sensors (Basel)       Date:  2012-07-23       Impact factor: 3.576

8.  Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells.

Authors:  Hannah Mak; Alexandra Naba; Sonal Varma; Colleen Schick; Andrew Day; Sandip K SenGupta; Monique Arpin; Bruce E Elliott
Journal:  BMC Cancer       Date:  2012-03-07       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.